» Authors » Shelley A Hall

Shelley A Hall

Explore the profile of Shelley A Hall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 806
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gong T, Hall S
Curr Opin Organ Transplant . 2023 Aug; 28(5):355-361. PMID: 37595099
Purpose Of Review: The revised United States heart organ allocation system was launched in October 2018. In this review, we summarize this United Network for Organ Sharing (UNOS) policy and...
12.
Alam A, Baran D, Doshi H, Van Zyl J, Patlolla S, Salem M, et al.
Artif Organs . 2023 Apr; 47(7):1094-1103. PMID: 37012224
Background: Right ventricular failure is associated with increased morbidity and mortality. The ProtekDuo (Livanova, Uk) is a dual-lumen cannula that allows for percutaneous right ventricular support and may be connected...
13.
Sawinski D, Lai J, Pinney S, Gray A, Jackson A, Stewart D, et al.
Am J Transplant . 2023 Mar; 23(3):316-325. PMID: 36906294
Solid organ transplantation provides the best treatment for end-stage organ failure, but significant sex-based disparities in transplant access exist. On June 25, 2021, a virtual multidisciplinary conference was convened to...
14.
Copeland H, Knezevic I, Baran D, Rao V, Pham M, Gustafsson F, et al.
J Heart Lung Transplant . 2022 Nov; 42(1):7-29. PMID: 36357275
The proposed donor heart selection guidelines provide evidence-based and expert-consensus recommendations for the selection of donor hearts following brain death. These recommendations were compiled by an international panel of experts...
15.
Jamil A, Tecson K, Ganz T, Blankenship S, Felius J, Carey S, et al.
Heart Lung . 2022 Aug; 57:41-44. PMID: 36027738
Background: Heart transplant recipients must regularly be assessed for graft rejection; however, endomyocardial biopsy (EMB), can be stressful, painful, and inconvenient. AlloMap® is the only commercially available non-invasive test for...
16.
Ebong I, Defilippis E, Hamad E, Hsich E, Randhawa V, Billia F, et al.
Front Cardiovasc Med . 2022 Jul; 9:890108. PMID: 35898277
Advanced heart failure (AHF) is associated with increased morbidity and mortality, and greater healthcare utilization. Recognition requires a thorough clinical assessment and appropriate risk stratification. There are persisting inequities in...
17.
John R, Kanwar M, Cleveland Jr J, Uriel N, Naka Y, Salerno C, et al.
J Thorac Cardiovasc Surg . 2022 Jun; 166(6):1684-1694.e18. PMID: 35643769
Background: Correction of valvular disease is often undertaken during left ventricular assist device (LVAD) implantation with uncertain benefit. We analyzed clinical outcomes with HeartMate 3 (HM3; Abbott) LVAD implantation in...
18.
Hall S, Copeland H, Alam A, Joseph S
Front Cardiovasc Med . 2022 May; 9:893327. PMID: 35557521
Right heart failure is a major cause of morbidity and mortality following left ventricular assist device implantation. Over the past few decades, the definition proposed by the Interagency Registry of...
19.
Afzal A, Van Zyl J, Nisar T, Kluger A, Jamil A, Felius J, et al.
Am J Cardiol . 2022 Apr; 171:99-104. PMID: 35365288
Heart failure (HF) affects 6 million people in the United States and costs $30 billion annually. It is unclear whether improvements in length of stay and mortality over the last...
20.
Afzal A, Alam A, Van Zyl J, Zafar H, Felius J, Hall S, et al.
Clin Transplant . 2021 Dec; 36(3):e14549. PMID: 34863042
Donor-derived cell free DNA (dd-cfDNA) has rapidly become part of rejection surveillance following orthotopic heart transplantation. However, some patients show elevated dd-cfDNA without clinical evidence of rejection. With the aim...